Research suggests people on rheumatoid arthritis drugs show weaker response to SARS-CoV-2 vaccines


Researchers conducted a comparative study among a cohort of individuals on rheumatoid arthritis (RA) therapies vis-à-vis healthy controls to assess their responses to coronavirus disease 2019 (COVID-19) vaccines.

AstraZeneca buys US biotech firm CinCor

Previous article

Medicaid and abortion top health agenda for Montana lawmakers

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News